Advertisement

Index by author

November 01, 1999; Volume 291,Issue 2

  1. Shams, Gamal

    1. β-Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human β-Adrenoceptors Expressed in Chinese Hamster Ovary Cells
      Anish A. Konkar, Sandeep S. Vansal, Gamal Shams, Paul F. Fraundorfer, Wei-Ping Zheng, Victor I. Nikulin, Joseph De Los Angeles, Richard H. Fertel, Duane D. Miller and Dennis R. Feller
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 875-883;

  2. Shimane, Miyuki

    1. Na+-Dependent Carnitine Transport by Organic Cation Transporter (OCTN2): Its Pharmacological and Toxicological Relevance
      Rikiya Ohashi, Ikumi Tamai, Hikaru Yabuuchi, Jun-Ichi Nezu, Asuka Oku, Yoshimichi Sai, Miyuki Shimane and Akira Tsuji
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 778-784;

  3. Shimizu, Hiroshi

    1. Mechanisms of Action of OPC-28326, a Selective Hindlimb Vasodilator
      Kensuke Orito, Takashi Imaizumi, Kenji Yoshida, Hiroyuki Fujiki, Masami Kishi, Shuji Teramoto, Michinori Tanaka, Hiroshi Shimizu, Michiaki Tominaga, Yukio Kimura, Junichi Kambayashi and Toyoki Mori
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 604-611;

  4. Shou, Magang

    1. Role of a Potent Inhibitory Monoclonal Antibody to Cytochrome P-450 3A4 in Assessment of Human Drug Metabolism
      Qin Mei, Cuyue Tang, Carol Assang, Yuh Lin, Donald Slaughter, A. David Rodrigues, Thomas A. Baillie, Thomas H. Rushmore and Magang Shou
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 749-759;

  5. Siekierka, John J.

    1. RWJ 67657, a Potent, Orally Active Inhibitor of p38 Mitogen-Activated Protein Kinase
      Scott A. Wadsworth, Druie E. Cavender, Scott A. Beers, Praful Lalan, Peter H. Schafer, Elizabeth A. Malloy, Wei Wu, Bohumila Fahmy, Gilbert C. Olini, Janet E. Davis, J. Lee Pellegrino-Gensey, Michael P. Wachter and John J. Siekierka
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 680-687;

  6. Slaughter, Donald

    1. Role of a Potent Inhibitory Monoclonal Antibody to Cytochrome P-450 3A4 in Assessment of Human Drug Metabolism
      Qin Mei, Cuyue Tang, Carol Assang, Yuh Lin, Donald Slaughter, A. David Rodrigues, Thomas A. Baillie, Thomas H. Rushmore and Magang Shou
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 749-759;

  7. Sloan, Donald E.

    1. Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice
      Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker, Konstantinos E. Tsaparikos, Donald E. Sloan, James D. Moyer, Elsa G. Barbacci, Leslie R. Pustilnik, Teresa A. Smolarek, John A. Davis, Madhur P. Vaidya, Lee D. Arnold, John L. Doty, Kenneth K. Iwata and Michael J. Morin
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 739-748;

  8. Slotkin, T. A.

    1. Agonist-Induced Sensitization of β-Adrenoceptor Signaling in Neonatal Rat Heart: Expression and Catalytic Activity of Adenylyl Cyclase
      J. L. Zeiders, F. J. Seidler and T. A. Slotkin
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 503-510;

  9. Smeda, John

    1. Effect of Poststroke Captopril Treatment on Mortality Associated with Hemorrhagic Stroke in Stroke-Prone Rats
      John Smeda, Sudesh Vasdev and Shelley R. King
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 569-575;

  10. Smith, Andrew D.

    1. An Unusual Ca2+ Entry Pathway Activated by Protein Kinase C in Dog Splenic Artery
      Mohammad A. Khoyi, Lisa G. Gregory, Andrew D. Smith, Kathleen D. Keef and David P. Westfall
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 823-828;
« Previous (Pages : 24 25 26 27 28 29 30 31 32 33 ... 35) Next »
Back to top

In this issue

Advertisement